Post-Grant Review May Impact Biosimilars Litigation
Post-grant review, created by the America Invents Act, is likely to have an impact on biosimilars litigation. PGR may prove to be an important forum for companies that do not want...To view the full article, register now.
Already a subscriber? Click here to view full article